A/C Enzymatic Vitamin B6 Assay
Radioassay, Vitamin B12. 510(k) K111260, from Anticancer, Inc. (San Diego, CA). Product code CDD, class 2.
As of Nov 20, 2026, K111260 is an FDA 510(k) held by Anticancer, Inc., substantially equivalent on Jul 26, 2012 after 448 days, with no recalls tied to it in FDA's recall database.
- Review time: 448 days
- Recalls: 0
INDICATION FOR USE STATEMENT: - The A/C Enzymatic Vitamin B6 Assay is intended for the quantitative determination of pyridoxal 5'-phosphate (PLP, vitamin B6) in EDTA-plasma. - The device will monitor vitamin $B_{6}$ (PLP) status in human plasma for aid in diagnosis of vitamin $B_{6}$ deficiency. • The A/C Enzymatic Vitamin B6 Assay is for IN VITRO DIAGNOSTIC USE ONLY.
- Buhlmann Vitamin B6 ReaK955561 · American Laboratory Products Co., Ltd. · May 23, 1996
- ARCHITECT Active-B12 (Holotranscobalamin)K233541 · Axis-Shield Diagnostics, Ltd. · Jul 31, 2024
- Access Vitamin B12K223289 · Beckman Coulter, Inc. · Dec 23, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 5, 2011
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1810
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files